Scientific programme

The scientific programme is structured around basic science, translational medicine and clinical sessions, given by some of the world’s top specialists. It also includes oral presentations of the best abstracts, the announcement of ECCO Fellowships and Grants and summary presentations of new ECCO Guidelines. The focus of all sessions is clinical practice founded on science, with practical messages to take home.
Scientific sessions are held from Thursday, February 15 to Saturday, February 17, 2018. The congress registration fee includes access to all scientific sessions.

Preliminary programme
(as of March 2017)

Science improving patients' lives

Thursday, February 15, 2018
Friday, February 16, 2018
Saturday, February 17, 2018

Plenary hall

11:00-12:00	Industry sponsored satellite symposia 1a & 1b
	12:15-12:20	Welcome Rainer Schöfl, Linz, Austria
	12:20-12:30	Opening Julián Panés, Barcelona, Spain
12:30-14:00	Scientific session 1: Exploring IBD over time Charlotte Hedin, Stockholm, Sweden Axel Dignass, Frankfurt/Main, Germany
	12:30-12:50	Can we diganose pre-symptomatic IBD? Joana Torres, Lisbon, Portugal
	12:50-13:00	Oral presentation 1 TBA
	13:00-13:20	Targeting early disease - lessons from rheumatoid arthritis Daniel Aletaha, Vienna, Austria
	13:20-13:30	Oral presentation 2 TBA
	13:30-13:40	Oral presentation 3 TBA
	13:40-14:00	Evolution of disease pathways over time in CD - early versus late disease Florian Rieder, Cleveland, United States
14:00-14:30	Coffee break
14:30-16:00	Scientific session 2: Novel treatment strategies Tim Raine, Cambridge, United Kingdom Matthieu Allez, Paris, France
	14:30-14:50	Combining new drugs with different mechanisms Shomron Ben-Horin, Ramat Gan, Israel
	14:50-15:00	Oral presentation 4 TBA
	15:00-15:20	Stem cell therapy for perianal CD - multidisciplinary management Damián García-Olmo, Madrid, Spain Silvio Danese, Milan, Italy
	15:20-15:30	Oral presentation 5 TBA
	15:30-15:40	Oral presentation 6 TBA
	15:40-16:00	Small molecules are back Laurent Peyrin-Biroulet, Nancy, France
16:00-17:20	Scientific session 3: The future of IBD Diagnosis and Disease Prediction Iris Dotan, Tel Aviv, Israel Jonas Halfvarson, Örebrö, Sweden
	16:00-16:20	ECCO-ESGAR Guidelines: Present and future of diagnostic techniques for IBD Jaap Stoker, Amsterdam, The Netherlands Christian Maaser, Lueneburg, Germany
	16:20-16:40	Molecular endoscopy for IBD Raja Atreya, Erlangen, Germany
	16:40-16:50	Oral presentation 7 TBA
	16:50-17:00	Oral presentation 8 TBA
	17:00-17:20	Integration of "omics" and potential for clinical practice Claudio Fiocchi, Cleveland, United States
17:30-18:30	Digital oral presentations (Sessions 1-5)
18:45-19:45	Industry sponsored satellite symposia 2a, 2b, 2c

Plenary hall

07:15-08:15	Industry sponsored satellite symposia 3a, 3b & 3c
08:30-10:30	Scientific session 4: Returning to a normal life with IBD Barry Hall, Dublin, Ireland Paula Ministro, Viseu, Portugal
	08:30-08:50	Sexual dysfunction in IBD patients Eugeni Domènech, Badalona, Spain
	08:50-09:00	Oral presentation 9 TBA
	09:00-09:10	Oral presentation 10 TBA
	09:10-09:20	Oral presentation 11 TBA
	09:20-09:40	How to prevent disability Jean-Frédéric Colombel, New York City, United States
	09:40-09:50	Oral presentation 12 TBA
	09:50-10:00	Oral presentation 13 TBA
	10:00-10:10	Oral presentation 14 TBA
	10:10-10:30	Patient perspective on treatment goals Corey Siegel, Lebanon, United States
10:30-11:00	Coffee Break
11:00-12:30	Scientific session 5: New opportunities for IBD care and research Dominik Bettenworth, Münster, Germany James Lindsay, London, United Kingdom
	11:00-11:20	Remote monitoring Daniel Baumgart, Berlin, Germany
	11:20-11:40	Point of care tests Ann Gils, Leuven, Belgium
	11:40-12:00	Web-based registries Pascal Juillerat, Bern, Switzerland
	12:00-12:10	Oral presentation 15 TBA
	12:10-12:30	Can the patient become an investigator? Germari Bianchi, Milan, Italy
12:30-13:30	Break
12:30-13:30	Guided poster session
12:40-13:20	Industry sponsored lunchtime satellite symposia LS1,LS2,LS3,LS4
13:30-15:00	Scientific session 6: Best perioperative management of IBD Yves Panis, Clichy, France Walter Reinisch, Vienna, Austria
	13:30-13:50	Get your patient fit for surgery Paulo Kotze, Curitiba, Brazil; Calgary, Canada Peter Irving, London, United Kingdom
	13:50-14:00	Oral presentation 16 TBA
	14:00-14:20	Enhanced postoperative recovery pathways Gionata Fiorino, Milan, Italy Antonino Spinelli, Milan, Italy
	14:20-14:30	Oral presentation 17 TBA
	14:30-14:40	Oral presentation 18 TBA
	14:40-15:00	Preventive strategy after resection surgery in CD Pierre Michetti, Lausanne, Switzerland
15:00-15:30	Coffee break
EITHER:
15:30-16:10	Scientific session 7: ECCO Fellowship and Grants Gerhard Rogler, Zurich, Switzerland Dino Tarabar, Belgrade, Serbia
	15:30-15:37	Outcomes from the ECCO-IOIBD Fellowship 2016 TBA
	15:37-15:44	Outcomes from the ECCO-IOIBD Fellowship 2017 TBA
	15:44-15:50	Announcement of ECCO Fellowships and Grants 2018 TBA
	15:50-16:00	Oral presentation 19 TBA
	16:00-16:10	Oral presentation 20 TBA
16:10-17:10	Scientific session 8: IBD Horizons Gerassimos Mantzaris, Athens, Greece Filip Baert, Roeselare, Belgium
	16:10-16:20	Oral presentation 21 TBA
	16:20-16:30	Oral presentation 22 TBA
	16:30-16:40	Oral presentation 23 TBA
	16:40-16:50	Oral presentation 24 TBA
	16:50-17:00	Oral presentation 25 TBA
	17:00-17:10	Oral presentation 26 TBA
OR:
15:30-17:10	Scientific session 9: Basic Science: Evolving concepts of IBD pathogenesis Britta Siegmund, Berlin, Germany Massimo Fantini, Rome, Italy